The R&D is already done for them. That's the expensive part of bringing the drug to market. But keep up the socialism.
“The R&D is already done for them.”
That’s true, which leaves no excuse for the major companies to continue the high prices after the R&D spent on a drug has been long paid off. Most of that profit doesn’t go back into R&D, it goes to the stockholders and CEOs. And they make sure to rig things their way to maximize how much they can line their pockets off of the sick and elderly.
You might be interested in the exchange toward the end of this thread...